Contemporary approaches to persistent atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 11, 2012, Pages 1421-1435

  Manlucu, Jaimie ^a   Brancato, Scott ^a   Lane, Christopher ^a   Kazemian, Pedram ^a   Michaud, Gregory F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

catheter ablation; complex fractionated atrial electrogram; persistent atrial fibrillation; pulmonary vein isolation

Indexed keywords

APIXABAN; DABIGATRAN; HEPARIN; RIVAROXABAN; WARFARIN;

CARDIOVASCULAR PROCEDURE; CATHETER ABLATION; CRITICAL ROTOR ABLATION; ENERGY RESOURCE; HEART ATRIUM FIBRILLATION; HUMAN; LINEAR ABLATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PULMONARY VEIN ISOLATION; REVIEW; SINUS RHYTHM; STERNOTOMY; SUPRAVENTRICULAR TACHYCARDIA; THORACOTOMY;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG RESISTANCE; EVIDENCE-BASED MEDICINE; HEART ATRIA; HUMANS; INDIVIDUALIZED MEDICINE; POSTOPERATIVE COMPLICATIONS; PULMONARY VEINS; RECURRENCE;

EID: 84871334554     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.136     Document Type: Review

References (109)

1. Lim TW, Jassal IS, Ross DL, Thomas SP. Medium-term efficacy of segmental ostial pulmonary vein isolation for the treatment of permanent and persistent atrial fibrillation. Pacing Clin. Electrophysiol. 29(4), 374-379 (2006).
2. Willems S, Klemm H, Rostock T et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur. Heart J. 27(23), 2871-2878 (2006).
3. Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D. The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc. Health Risk Manag. 7, 193-202 (2011).
4. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Van den Berg MP, Crijns HJ. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog. Cardiovasc. Dis. 48(3), 153-168 (2005).
5. Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ. J. 68(6), 568-572 (2004).
6. Calkins H, Kuck KH, Cappato R et al.; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9(4), 632-696.e21 (2012).
7. Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659-666 (1998).
8. Knecht S, O'Neill MD, Matsuo S et al. Focal arrhythmia confined within the coronary sinus and maintaining atrial fibrillation. J. Cardiovasc. Electrophysiol. 18(11), 1140-1146 (2007).
9. Lin WS, Tai CT, Hsieh MH et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 107(25), 3176-3183 (2003).
10. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91(1), 265-325 (2011).
11. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92(7), 1954-1968 (1995).
12. Kalifa J, Jalife J, Zaitsev AV et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 108(6), 668-671 (2003).
13. Guo H, Euler D, Wang Z, Olshansky B. Autonomic influences in atrial ischemia: vagally mediated atrial conduction improvement. Int. J. Cardiol. 61(2), 157-163 (1997).
14. Olshansky B. Interrelationships between the autonomic nervous system and atrial fibrillation. Prog. Cardiovasc. Dis. 48(1), 57-78 (2005).
15. Haïssaguerre M, Sanders P, Hocini M, Jaïs P, Clémenty J. Pulmonary veins in the substrate for atrial fibrillation: the 'venous wave' hypothesis. J. Am. Coll. Cardiol. 43(12), 2290-2292 (2004).
16. Haïssaguerre M, Sanders P, Hocini M et al. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 109(24), 3007-3013 (2004).
17. Pappone C, Oreto G, Rosanio S et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104(21), 2539-2544 (2001).
18. Arentz T, von Rosenthal J, Blum T et al. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation 108(20), 2484-2490 (2003).
19. Khan A, Mittal S, Kamath GS, Garikipati NV, Marrero D, Steinberg JS. Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling. J. Cardiovasc. Electrophysiol. 22(2), 142-148 (2011).
20. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ. Arrhythm. Electrophysiol. 2(6), 626-633 (2009).
21. Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354(9), 934-941 (2006).
22. Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 43(11), 2044-2053 (2004).
23. Saghy L, Callans DJ, Garcia F et al. Is there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation? Heart Rhythm 9(2), 181-188 (2012).
24. Oral H, Chugh A, Good E et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 115(20), 2606-2612 (2007).
25. Verma A, Mantovan R, Macle L et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur. Heart J. 31(11), 1344-1356 (2010).
26. Lin YJ, Tai CT, Chang SL et al. Efficacy of additional ablation of complex fractionated atrial electrograms for catheter ablation of nonparoxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 20(6), 607-615 (2009).
27. Oral H, Chugh A, Yoshida K et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J. Am. Coll. Cardiol. 53(9), 782-789 (2009).
28. Elayi CS, Verma A, Di Biase L et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm 5(12), 1658-1664 (2008).
29. Verma A, Patel D, Famy T et al. Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 18(2), 151-156 (2007).
30. Hayward RM, Upadhyay GA, Mela T et al. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: a meta-analysis. Heart Rhythm 8(7), 994-1000 (2011).
31. Dixit S, Marchlinski FE, Lin D et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ. Arrhythm. Electrophysiol. 5(2), 287-294 (2011).
32. Aizer A, Holmes DS, Garlitski AC et al. Standardization and validation of an automated algorithm to identify fractionation as a guide for atrial fibrillation ablation. Heart Rhythm 5(8), 1134-1141 (2008).
33. Monir G, Pollak SJ. Consistency of the CFAE phenomena using custom software for automated detection of complex fractionated atrial electrograms (CFAEs) in the left atrium during atrial fibrillation. J. Cardiovasc. Electrophysiol. 19(9), 915-919 (2008).
34. Yoshida K, Chugh A, Good E et al. A critical decrease in dominant frequency and clinical outcome after catheter ablation of persistent atrial fibrillation. Heart Rhythm 7(3), 295-302 (2010).
35. Verma A, Lakkireddy D, Wulffhart Z et al. Relationship between complex fractionated electrograms (CFE) and dominant frequency (DF) sites and prospective assessment of adding DF-guided ablation to pulmonary vein isolation in persistent atrial fibrillation (AF). J. Cardiovasc. Electrophysiol. 22(12), 1309-1316 (2011).
36. Narayan S SK, Mittal S et al. Conventional Ablation for Atrial Fibrillation with or without Focal Impulse and Rotor Modulation (the CONFIRM trial). Presented at: Heart Rhythm 32nd Annual Scientific Sessions. San Francisco, CA, USA (2011).
37. Jaïs P, Hocini M, O'Neill MD et al. How to perform linear lesions. Heart Rhythm 4(6), 803-809 (2007).
38. Jaïs P, Hocini M, Hsu LF et al. Technique and results of linear ablation at the mitral isthmus. Circulation 110(19), 2996-3002 (2004).
39. Hocini M, Jaïs P, Sanders P et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 112(24), 3688-3696 (2005).
40. Brooks AG, Stiles MK, Laborderie J et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 7(6), 835-846 (2010).
41. Earley MJ, Abrams DJ, Staniforth AD, Sporton SC, Schilling RJ. Catheter ablation of permanent atrial fibrillation: medium term results. Heart 92(2), 233-238 (2006).
42. Fiala M, Chovancík J, Wojnarová D et al. Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. J. Interv. Card. Electrophysiol. 23(3), 189-198 (2008).
43. Gaita F, Di Donna P, Olivotto I et al. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am. J. Cardiol. 99(11), 1575-1581 (2007).
44. Miyazaki S, Kuwahara T, Takahashi A et al. Effect of left atrial ablation on the quality of life in patients with atrial fibrillation. Circ. J. 72(4), 582-587 (2008).
45. Seow SC, Lim TW, Koay CH, Ross DL, Thomas SP. Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation. Europace 9(12), 1129-1133 (2007).
46. Estner HL, Hessling G, Biegler R et al. Complex fractionated atrial electrogram or linear ablation in patients with persistent atrial fibrillation - a prospective randomized study. Pacing Clin. Electrophysiol. 34(8), 939-948 (2011).
47. Knecht S, Hocini M, Wright M et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur. Heart J. 29(19), 2359-2366 (2008).
48. Tan AY, Li H, Wachsmann-Hogiu S, Chen LS, Chen PS, Fishbein MC. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J. Am. Coll. Cardiol. 48(1), 132-143 (2006).
49. Pappone C, Santinelli V, Manguso F et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109(3), 327-334 (2004).
50. Matsuo S, Yamane T, Date T et al. Completion of mitral isthmus ablation using a steerable sheath: prospective randomized comparison with a nonsteerable sheath. J. Cardiovasc. Electrophysiol. 22(12), 1331-1338 (2011).
51. Bhargava M, Di Biase L, Mohanty P et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 6(10), 1403-1412 (2009).
52. Higa S, Tai CT, Chen SA. Catheter ablation of atrial fibrillation originating from extrapulmonary vein areas: Taipei approach. Heart Rhythm 3(11), 1386-1390 (2006).
53. Haïssaguerre M, Hocini M, Sanders P et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 113(5), 616-625 (2006).
54. Calò L, Lamberti F, Loricchio ML et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. J. Am. Coll. Cardiol. 47(12), 2504-2512 (2006).
55. Pontoppidan J, Nielsen JC, Poulsen SH et al. Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial. Heart 95(12), 994-999 (2009).
56. Oral H, Chugh A, Good E et al. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation. Circ. Arrhythm. Electrophysiol. 1(1), 6-13 (2008).
57. Smelley MP, Knight BP. Approaches to catheter ablation of persistent atrial fibrillation. Heart Rhythm 6(Suppl. 8), S33-S38 (2009).
58. O'Neill MD, Jaïs P, Takahashi Y et al. The stepwise ablation approach for chronic atrial fibrillation - evidence for a cumulative effect. J. Interv. Card. Electrophysiol. 16(3), 153-167 (2006).
59. Oral H. Catheter ablation for chronic atrial fibrillation. Heart Rhythm 4(5), 691-694 (2007).
60. Matsuo S, Lellouche N, Wright M et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J. Am. Coll. Cardiol. 54(9), 788-795 (2009).
61. Haïssaguerre M, Hocini M, Sanders P et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol. 16(11), 1138-1147 (2005).
62. Haïssaguerre M, Sanders P, Hocini M et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J. Cardiovasc. Electrophysiol. 16(11), 1125-1137 (2005).
63. Takahashi Y, O'Neill MD, Hocini M et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J. Am. Coll. Cardiol. 51(10), 1003-1010 (2008).
64. O'Neill MD, Wright M, Knecht S et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur. Heart J. 30(9), 1105-1112 (2009).
65. Sacher F, Corcuff JB, Schraub P et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur. Heart J. 29(10), 1290-1295 (2008).
66. Rostock T, Salukhe TV, Steven D et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm 8(9), 1391-1397 (2011).
67. Rostock T, Steven D, Hoffmann B et al. Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ. Arrhythm. Electrophysiol. 1(5), 344-353 (2008).
68. Elayi CS, Di Biase L, Barrett C et al. Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm 7(9), 1216-1223 (2010).
69. Gula LJ, Massel D, Leong-Sit P et al. Does adenosine response predict clinical recurrence of atrial fibrillation after pulmonary vein isolation? J. Cardiovasc. Electrophysiol. 22(9), 982-986 (2011).
70. Miyazaki S, Kuwahara T, Kobori A et al. Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation. J. Cardiovasc. Electrophysiol. 23(3), 256-260 (2012).
71. Yamane T, Matsuo S, Date T et al. Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure. Circ. Arrhythm. Electrophysiol. 4(5), 601-608 (2011).
72. Datino T, Macle L, Chartier D et al. Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation. Heart Rhythm 8(9), 1426-1433 (2011).
73. Jaïs P, Hocini M, Sanders P et al. Longterm evaluation of atrial fibrillation ablation guided by noninducibility. Heart Rhythm 3(2), 140-145 (2006).
74. Essebag V, Baldessin F, Reynolds MR et al. Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur. Heart J. 26(23), 2550-2555 (2005).
75. Lee G, Kalman JM. Endpoints in ablation of paroxysmal atrial fibrillation: when is enough enough? J. Cardiovasc. Electrophysiol. 21(4), 389-392 (2010).
76. Adlbrecht C. Gwechenberger M, Richter B, Sipötz J, Kaider A, Gössinger H. Prognostic value of induction of atrial fibrillation before and after pulmonary vein isolation. Int. J. Cardiol. 10.1016/j. ijcard.2011.07.023 (2011) (Epub ahead of print).
77. Dewire J, Calkins H. State-of-the-art and emerging technologies for atrial fibrillation ablation. Nat. Rev. Cardiol. 7(3), 129-138 (2010).
78. Miyazaki S, Kuwahara T, Kobori A et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 97(8), 668-673 (2011).
79. Jaïs P, Matsuo S, Knecht S et al. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J. Cardiovasc. Electrophysiol. 20(5), 480-491 (2009).
80. Shah AJ, Jadidi A, Liu X et al. Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn? Cardiol. Res. Pract. 2010, 950763 (2010).
81. Baman TS, Gupta SK, Billakanty SR et al. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome. J. Cardiovasc. Electrophysiol. 20(12), 1321-1325 (2009).
82. Veenhuyzen GD, Knecht S, O'Neill MD et al. Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management. Pacing Clin. Electrophysiol. 32(3), 393-398 (2009).
83. Themistoclakis S, Schweikert RA, Saliba WI et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm 5(5), 679-685 (2008).
84. Leong-Sit P, Roux JF, Zado E et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ. Arrhythm. Electrophysiol. 4(1), 11-14 (2011).
85. Adams HP Jr, del Zoppo G, Alberts MJ et al.; American Heart Association/ American Stroke Association Stroke Council; American Heart Association/ American Stroke Association Clinical Cardiology Council; American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease Working Group; Quality of Care Outcomes in Research Interdisciplinary Working Group. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115(20), e478-e534 (2007).
86. Kwak JJ, Pak HN, Jang JK et al. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 21(6), 620-625 (2010).
87. Di Biase L, Burkhardt JD, Mohanty P et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation 121(23), 2550-2556 (2010).
88. Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA. The use of dabigatran immediately after atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 23(3), 264-268 (2012).
89. Lakkireddy D, Reddy YM, Di Biase L et al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J. Am. Coll. Cardiol. 59(13), 1168-1174 (2012).
90. Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3(1), 32-38 (2010).
91. Cappato R, Calkins H, Chen SA et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J. Am. Coll. Cardiol. 53(19), 1798-1803 (2009).
92. Spragg DD, Dalal D, Cheema A et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J. Cardiovasc. Electrophysiol. 19(6), 627-631 (2008).
93. Prasad SM, Maniar HS, Camillo CJ et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J. Thorac. Cardiovasc. Surg. 126(6), 1822-1828 (2003).
94. Damiano RJ Jr. Alternative energy sources for atrial ablation: judging the new technology. Ann. Thorac. Surg. 75(2), 329-330 (2003).
95. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation; a systematic review. Eur. J. Cardiothorac. Surg. 27(2), 258-265 (2005).
96. Damiano RJ. Surgical ablation of lone atrial fibrillation on the beating heart: the chaos continues. Europace 12(3), 297-298 (2010).
97. Onorati F, Curcio A, Santarpino G et al. Routine ganglionic plexi ablation during Maze procedure improves hospital and early follow-up results of mitral surgery. J. Thorac. Cardiovasc. Surg. 136(2), 408-418 (2008).
98. Wisser W, Seebacher G, Fleck T et al. Permanent chronic atrial fibrillation: is pulmonary vein isolation alone enough? Ann. Thorac. Surg. 84(4), 1151-1157 (2007).
99. Edgerton JR, Jackman WM, Mack MJ. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. J. Interv. Card. Electrophysiol. 20(3), 89-93 (2007).
100. Weimar T, Bailey MS, Watanabe Y et al. The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J. Interv. Card. Electrophysiol. 31(1), 47-54 (2011).
101. Weimar T, Schena S, Bailey MS et al. The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ. Arrhythm. Electrophysiol. 5(1), 8-14 (2012).
102. Boersma LV, Castella M, van Boven W et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 125(1), 23-30 (2012).
103. Geidel S, Krause K, Boczor S et al. Ablation surgery in patients with persistent atrial fibrillation: an 8-year clinical experience. J. Thorac. Cardiovasc. Surg. 141(2), 377-382 (2011).
104. Beukema WP, Sie HT, Misier AR, Delnoy PP, Wellens HJ, Elvan A. Intermediate to long-term results of radiofrequency modified Maze procedure as an adjunct to open-heart surgery. Ann. Thorac. Surg. 86(5), 1409-1414 (2008).
105. Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J. Thorac. Cardiovasc. Surg. 118(5), 833-840 (1999).
106. Dawson AG, Asopa S, Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact. Cardiovasc. Thorac. Surg. 10(2), 306-311 (2010).
107. Salzberg SP, Plass A, Emmert MY et al. Left atrial appendage clip occlusion: early clinical results. J. Thorac. Cardiovasc. Surg. 139(5), 1269-1274 (2010).
108. Singh SM, D'Avila A, Kim YH et al. The Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (MAGICAF) Study: clinical background and study design. J. Cardiovasc. Electrophysiol. 23(4), 352-358 (2011).
109. Katritsis D, Merchant FM, Mela T, Singh JP, Heist EK, Armoundas AA. Catheter ablation of atrial fibrillation the search for substrate-driven end points. J. Am. Coll. Cardiol. 55(21), 2293-2298 (2010).